1. PLoS Med. 2007 Dec;4(12):e346. doi: 10.1371/journal.pmed.0040346.

Should we include connection domain mutations of HIV-1 reverse transcriptase in 
HIV resistance testing.

GÃ¶tte M(1).

Author information:
(1)Department of Microbiology and Immunology, McGill University, Montreal, 
Quebec, Canada. matthias.gotte@mcgill.ca

Comment on
    PLoS Med. 2007 Dec;4(12):e335. doi: 10.1371/journal.pmed.0040335.

The author discusses a new study that found a common mutation in the connection 
domain of reverse transcriptase, a mutation that confers resistance to two 
antiretroviral drug classes.

DOI: 10.1371/journal.pmed.0040346
PMCID: PMC2100139
PMID: 18052605 [Indexed for MEDLINE]

Conflict of interest statement: Competing Interests: The author has declared 
that no competing interests exist.